Primary metastatic Ewing's family tumors: Results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation

Annals of Oncology

Volumn 23, Issue 11, 2012, Pages 2970-2976

  Luksch, R ^a   Tienghi, A ^b   Sundby Hall, K ^c   Fagioli, F ^d   Picci, P ^e   Barbieri, E ^f   Gandola, L ^a   Eriksson, M ^g   Ruggieri, P ^e   Daolio, P ^h   Lindholm, P ⁱ   Prete, A ^f   Bisogno, G ^j   Tamburini, A ^k   Grignani, G ^l   Abate, M E ^e   Podda, M ^a   Smeland, S ^c   Ferrari, S ^e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^e RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g LUND UNIVERSITY   (Sweden)

^h ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j UNIVERSITY OF PADOVA   (Italy)

^k UNIVERSITY OF FLORENCE   (Italy)

^l CANDIOLO CANCER INSTITUTE   (Italy)

more..

Author keywords

Ewing's sarcoma; High dose chemotherapy; Lung metastases; Total lung irradiation

Indexed keywords

EID: 84868149746     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds117     Document Type: Article

References (36)

1. Bernstein M, Kovar H, Paulussen M et al. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In Pizzo PA, Poplack D (eds), Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott Raven 2006; 1002-1032.
2. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-2114.
3. Paulussen M, Ahrens S, Craft AW et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 1998; 16: 3044-3052.
4. Paulussen M, Ahrens S, Burdach S et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies- European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998; 9: 275-281.
5. Eralp Y, Bavbek S, Basaran M et al. Prognostic factors and survival in late adolescent and adult patients with small round cell tumors. Am J Clin Oncol 2002; 25: 418-424.
6. Kushner BH, Meyers PA, Gerald WL et al. Very-high dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma in children and young adults. J Clin Oncol 1995; 13: 2796-2804.
7. Ladenstein R, Lasset C, Pinkerton R et al. Impact of megatherapy in children with high-risk Ewing's tumors in complete remission: a report from the EBMT Solid Tumor Registry. Bone Marrow Transplant 1995; 15: 697-705.
8. Oberlin O, Rey A, Desfashelles AS et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societè Francais des Cancers de l'Enfant. J Clin Oncol 2006; 24: 3997-4002.
9. Burdach S, Juergens H. High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002; 41: 169-189.
10. Laurence V, Pierga JY, Barthier S et al. Long-term follow-up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor. Am J Clin Oncol 2005; 28: 301-309.
11. Nesbit ME, Jr, Gehan EA, Burghert EO, Jr et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a longterm follow-up of the First Intergroup Study. J Clin Oncol 1990; 8: 1664-1674.
12. Spunt SL, McCarville MB, Kun LE et al. Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis. J Pediatr Hematol Oncol 2001; 23: 93-98.
13. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106-120.
14. Picci P, Bohling T, Bacci G et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997; 15: 1553-1559.
15. Ferrari S, Sundby Hall K, Luksch R et al. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III Protocol. Ann Oncol 2011; 22: 1221-1227.
16. Picci P, Taskdal I, Malaguti MC et al. A good response to induction chemotherapy in Ewing/PNET tumors evaluated by imaging correlates both histological necrosis and survival. An Italian Sarcoma Group/Scandinavian Sarcoma Group Study. Proc Am Soc Clin Oncol 1999; 18: 556. (Abstr 2145)
17. Peto P, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
18. Bernstein ML, Devidas M, Lafreniere D et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group phase II Study 9457-a report from the Children's Oncology Group. J Clin Oncol 2006; 24: 152-159.
19. Prete A, Rosito P, Alvisi P et al. G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood. Bone Marrow Transplant 1998; 22Suppl 5S21-S23.
20. Diaz MA, Lassaletta A, Perez A et al. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk Ewing sarcoma patients: a long-term follow-up single-center study. Pediatric Hematol Oncol 2010; 27: 272-282.
21. Atra A, Wheelan JS, Calvagna V et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant 1997; 20: 843-846.
22. Ilari I, De Ioris MA, Milano GM et al. Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital. Bone Marrow Transplantation 2010; 45: 1274-1280.
23. Al-Faris N, Harbi TA, Goia C et al. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?. Pediatr Blood Cancer 2007; 49: 190-195.
24. Ladenstein R, Poetschger U, Le Deley MC et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING-99 99 trial. J Clin Oncol 2010; 28: 3284-3291.
25. Cangir A, Vietti TJ, Gehan EA et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two Intergroup Ewing's Sarcoma Studies. Cancer 1990; 66: 887-893.
26. Whelan JS, Burcombe RJ, Janinis J et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumors. Ann Oncol 2002; 13: 23-30.
27. Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of the bone. N Engl J Med 2003; 348: 694-701.
28. Carrie C, Le Delay MC, Claude L et al. The radiosensitization and toxicity of busulfan-containing chemotherapy before radiotherapy for Ewing's sarcomas. Strahlenther Onkol 2009; 185Sondernr 231
29. Bolling T, Dirksen U, Ranft A et al. Radiation toxicity following busulfan/ melphalan high-dose chemotherapy in the Euro-EWING-99-trial: review of GPOH data. Strahlenther Onkol 2009; 185Sondernr 221-22.
30. Paulussen M, Craft AW, Lewis I et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008; 26: 4385-4393.
31. Kuttesch JF, Jr, Wexler LH, Marcus RB et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996; 14: 2818-2825.
32. Granowetter L, Womer R, Devidas M et al. Dose-intensified compared with standard chemotherapy for nonmetastatic sarcoma family tumors: a Children's Oncology Group Study. J Clin Oncol 2009; 27: 2536-2541.
33. Bacci G, Forni C, Longhi A et al. Long-term outcome for patients with nonmetastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40: 73-83.
34. Motosue MS, Zhu L, Srivastava K et al. Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. Cancer 2012; 118: 1450-1456.
35. Oberlin O, Deley MC, Bui BN et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001; 85: 1646-1654.
36. Paulussen M, Ahrens D, Dunst J et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study EICESS 86. J Clin Oncol 2001; 19: 1818-1829.